Oncopeptides — Major Shareholding Notification 2021

Nov 16, 2021

Issuer Oncopeptides AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument

Instrument	Aktier
Before the transaction
Shares	Data not given*
Voting rights	Data not given*
Transaction
Reason for major shareholding notification Sell
Date	15/11/2021
Limit for number of shares	5 %
Limit for number of votes	5 %
After the transaction
Quantity
Shares	3,723,246
Directly held voting rights	0
Indirectly held voting rights	3,723,246
Percentage
Directly held shares	4.94509 %
Directly held voting rights	0 %
Indirectly held voting rights	4.94509 %

Resulting distribution of total holdings

	Percentage of voting rights:	Number of underlying shares:
Shares	4.94509 %	3,723,246
Instruments - FITA Ch. 4, section 2, first paragraph, line 2
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
- Physically settled
- Cash settled	0.00003 %	19
Total	4.94512 %	3,723,265

Group total holdings

Voting rights 3,723,265 Percentage of voting rights 4.94512

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.

Published

16/11/2021 13:08

Contact

Name Magnus Westerman

Email magnus.westerman@avanza.se

*Source of information has chosen not to submit the data

rapportering@fi.se Tfn 08-408 980 37 Fax 08-24 39 25